• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis - Product Image

Pediatric Vaccines Market, Doses, Immunization, Cases and Forecast: Worldwide Analysis

  • Published: December 2012
  • Region: Global
  • 116 Pages
  • Renub Research

Worldwide pediatric vaccine market has been growing rapidly over the last five years as it has doubled its market share in 2011 compared to 2005. The worldwide pediatrics vaccine market is expected to be more than US$ 23 Billion by 2015 growing with a single digit CAGR during 2012 – 2015. This incremental growth has been due to blockbuster vaccines (Prevnar7, Prevnar 13, Rotarix and Rotateq) sales in Billion of US$ which made a significant contribution.

It is predicted that Pediatric proprietary vaccines will lead the segment with little less than 60% market share by 2015.The combinations & boosters and enhanced pediatric vaccines market are expected to show stagnant growth in future due to lower margins and the mature nature of these markets. Pneumococcal, DTP and Varicella together all these three vaccines control 55% of the market share in 2011.

In number of cases Polio, Haemophiilus Influenzae Type B (HIB) and MMR cases have shown decline continuously from the year 2001 till 2011. Polio remains endemic merely in three countries and the good news is that India has not reported a single case from the past two years and on the verge of being called a polio READ MORE >

1. Executive Summary

2. Worldwide Pediatric Vaccines Market and Forecast (2006 – 2015)

3. Worldwide – Pediatric Vaccines Market Share & Forecast (Sector wise) (2005 – 2015)

4. Worldwide – Pediatric Vaccines Market Share & Forecast (Disease wise) (2006 – 2015)

5. By Sector – Pediatric Vaccines Market and Forecast (2005 – 2015)
5.1 Worldwide – Pediatric Combinations & Boosters Vaccines Market
5.2 Worldwide – Pediatric Enhanced Combinations Vaccines Market
5.3 Worldwide – Pediatric Proprietary Vaccines Market

6. Major Pediatric Vaccines Cases, Doses, Immunization Coverage, Market and Forecast
6.1 Measles, Mumps & Rubella (MMR) Vaccines and Forecast (2005 – 2015)
6.1.1 Number of Measles, Mumps & Rubella Cases (2001 – 2011)
6.1.2 Number of Measles, Mumps & Rubella (MMR) Vaccines Doses
6.1.3 Immunization Coverage of Measles, Mumps & Rubella (MMR) Vaccines
6.1.4 Market Size of Measles, Mumps & Rubella (MMR) Vaccines

6.2 Haemophilus Influenzae Type B (HIB) Vaccines and Forecast (2005 – 2015)
6.2.1 Number of Haemophilus Influenzae Type B (HIB) Meningitis Cases (2001 – 2011)
6.2.2 Number of Haemophilus Influenzae Type B (HIB) Vaccines Doses
6.2.3 Immunization Coverage of Haemophilus Influenzae Type B (HIB) Vaccines
6.2.4 Market Size of Haemophilus Influenzae Type B (HIB) Vaccines

6.3 Polio Vaccines and Forecast (2005 – 2015)
6.3.1 Number of Polio Cases (2001 – 2011)
6.3.2 Number of Polio Vaccines Doses
6.3.3 Immunization Coverage of Polio Vaccines
6.3.4 Market Size of Polio Vaccines

6.4 Diphtheria, Tetanus & Pertussis (Combos) Vaccines and Forecast (2005 – 2015)
6.4.1 Number of Diphtheria, Tetanus & Pertussis (DTP) Cases (2001 – 2011)
6.4.2 Number of Diphtheria, Tetanus & Pertusis (DTP) Vaccines Doses
6.4.3 Immunization Coverage of Diphtheria, Tetanus & Pertusis (DTP) Vaccines
6.4.4 Market Size of Diphtheria, Tetanus & Pertussis (Combos) Vaccines

6.5 Pneumococcal Vaccines and Forecast (2005 – 2015)
6.5.1 Number of Pneumococcal Cases (2000)
6.5.2 Number of Pneumococcal Vaccines Doses
6.5.3 Immunization Coverage of Pneumococcal Vaccines
6.5.4 Market Size of Pneumococcal Vaccines

6.6 Rotavirus Vaccine and Forecast (2006 – 2015)
6.6.1 Number of Rotavirus Cases (2008 & 2009)
6.6.2 Number of Rotavirus Vaccines Doses
6.6.3 Immunization Coverage of Rotavirus Vaccines
6.6.4 Market Size of Rotavirus Vaccine

6.7 Hepatitis Pediatric Vaccines and Forecast (2005 – 2015)
6.7.1 Number of Hepatitis Pediatric Vaccines Doses
6.7.2 Immunization Coverage of Hepatitis Pediatric Vaccines
6.7.3 Market Size of Hepatitis Pediatric Vaccines

6.8 Varicella/Chicken Pox Vaccines and Forecast (2005 – 2015)
6.8.1 Number of Varicella/Chicken Pox Vaccines Doses
6.8.2 Market Size of Varicella/Chicken Pox Vaccines

6.9 Other Pediatric Vaccines and Forecast (2005 – 2015)
6.9.1 Market Size of Other Pediatric Vaccines

7. Growth Drivers of Pediatric Vaccines Market
7.1 Reduced Price on Rotavirus Vaccines: Enough to Facilitate Growth but More Still Needs To Be Done
7.1.1 Rotavirus Vaccine Introduction
7.1.2 Financial Challenges
7.1.3 Cost Effective
7.1.4 Future Steps
7.1.5 Conclusion

7.2 GAVI Model Increases Vaccine Manufacturers
7.2.1 The Partnership Model
7.2.2 The Business Model

7.3 WHO Global Vaccine Action Plan (2011 - 2020)

8. Challenges of Pediatric Vaccine Market
8.1 Roadblocks in Expanding Access to Newer Pediatric Vaccines
8.2 Impediment in Pediatric Vaccine Research & Development
8.3 Barriers to New Entrants in the Pediatric Vaccines Market

List of Figures

Figure 2 1: Worldwide – Pediatric Vaccines Market (Million US$), 2006 – 2011
Figure 2 2: Worldwide – Forecast for Pediatric Vaccines Market (Million US$), 2012 – 2015

Figure 3 1: Worldwide (Sector wise) – Pediatric Vaccines Market Share (Percent), 2005 – 2011
Figure 3 2: Worldwide (Sector wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015

Figure 5 1: Worldwide – Pediatric Combinations & Boosters Vaccines Market (Million US$), 2005 – 2011
Figure 5 2: Worldwide – Forecast for Pediatric Combinations & Boosters Vaccines Market (Million US$), 2012 – 2015
Figure 5 3: Worldwide – Pediatric Enhanced Combinations Vaccines Market (Million US$), 2005 – 2011
Figure 5 4: Worldwide – Forecast for Pediatric Enhanced Combinations Vaccines Market (Million US$), 2012 – 2015
Figure 5 5: Worldwide – Pediatric Proprietary Vaccines Market (Million US$), 2005 – 2011
Figure 5 6: Worldwide – Forecast for Pediatric Proprietary Vaccines Market (Million US$), 2012 – 2015

Figure 6 1: Worldwide – Number of MMR Vaccines Doses (Million Doses), 2005 – 2011
Figure 6 2: Worldwide – Forecast for Number of MMR Vaccines Doses (Million Doses), 2012 – 2015
Figure 6 3: Worldwide – Immunization Coverage of MMR Vaccines Doses (Million Doses), 2005 – 2011
Figure 6 4: Worldwide – Forecast for Immunization Coverage of MMR Vaccines Doses (Million Doses), 2012 – 2015
Figure 6 5: Worldwide – Measles, Mumps & Rubella Vaccines Market (Million US$), 2005 – 2011
Figure 6 6: Worldwide – Forecast for Measles, Mumps & Rubella Vaccines Market (Million US$), 2012 – 2015
Figure 6 7: Worldwide – Haemophilus Influenzae Type B Vaccine Introduction in High & Low-Income Countries, 1980 – 2010
Figure 6 8: Worldwide – Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011
Figure 6 9: Worldwide – Forecast for Number of Doses of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015
Figure 6 10: Worldwide – Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2005 – 2011
Figure 6 11: Worldwide – Forecast for Immunization Coverage of Haemophilus Influenzae Type B Vaccines (Million Doses), 2012 – 2015
Figure 6 12: Worldwide – Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2005 – 2011
Figure 6 13: Worldwide – Forecast for Haemophilus Influenzae Type B (HIB) Vaccines Market (Million US$), 2012 – 2015
Figure 6 14: Worldwide – Number of Doses of Polio Vaccines (Million Doses), 2005 – 2011
Figure 6 15: Worldwide – Forecast for Number of Doses of Polio Vaccines (Million Doses), 2012 – 2015
Figure 6 16: Worldwide – Immunization Coverage of Polio Vaccines (Million Doses), 2005 – 2011
Figure 6 17: Worldwide – Forecast for Immunization Coverage of Polio Vaccines (Million Doses), 2012 – 2015
Figure 6 18: Worldwide – Polio Vaccines Market (Million US$), 2005 – 2011
Figure 6 19: Worldwide – Forecast for Polio Vaccines Market (Million US$), 2012 – 2015
Figure 6 20: Worldwide – Number of Doses of DTP Vaccines (Million Doses), 2005 – 2011
Figure 6 21: Worldwide – Forecast for Number of Doses of DTP Vaccines (Million Doses), 2012 – 2015
Figure 6 22: Worldwide – Immunization Coverage of DTP Vaccines (Million Doses), 2005 – 2011
Figure 6 23: Worldwide – Forecast for Immunization Coverage of DTP Vaccines (Million Doses), 2012 – 2015
Figure 6 24: Worldwide – Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2005 – 2011
Figure 6 25: Worldwide – Forecast for Diphtheria, Tetanus & Pertussis (Combos) Vaccines Market (Million US$), 2012 – 2015
Figure 6 26: Worldwide – Pneumococcal Vaccine Pipeline, 2000 – 2025
Figure 6 27: Worldwide – Number of Doses of Pneumococcal Vaccines (Million Doses), 2010 – 2011
Figure 6 28: Worldwide – Forecast for Number of Doses of Pneumococcal Vaccines (Million Doses), 2012 – 2015
Figure 6 29: Worldwide – Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2010 – 2011
Figure 6 30: Worldwide – Forecast for Immunization Coverage of Pneumococcal Vaccines (Million Doses), 2012 – 2015
Figure 6 31: Worldwide – Pneumococcal Vaccines Market (Million US$), 2005 – 2011
Figure 6 32: Worldwide – Forecast for Pneumococcal Vaccines Market (Million US$), 2012 – 2015
Figure 6 33: Worldwide – Number of Doses of Rotavirus Vaccines (Million Doses), 2010 – 2011
Figure 6 34: Worldwide – Forecast for Number of Doses of Rotavirus Vaccines (Million Doses), 2012 – 2015
Figure 6 35: Worldwide – Immunization Coverage of Rotavirus Vaccines (Million Doses), 2010 – 2011
Figure 6 36: Worldwide – Forecast for Immunization Coverage of Rotavirus Vaccines (Million Doses), 2012 – 2015
Figure 6 37: Worldwide – Rotavirus Vaccine Market (Million US$), 2006 – 2011
Figure 6 38: Worldwide – Forecast for Rotavirus Vaccine Market (Million US$), 2012 – 2015
Figure 6 39: Worldwide – Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011
Figure 6 40: Worldwide – Forecast for Number of Doses of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015
Figure 6 41: Worldwide – Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2005 – 2011
Figure 6 42: Worldwide – Forecast for Immunization Coverage of Hepatitis Pediatric Vaccines (Million Doses), 2012 – 2015
Figure 6 43: Worldwide – Hepatitis B Vaccine Introduction in High & Low-income countries, 1980 – 2010
Figure 6 44: Worldwide – Hepatitis Pediatric Vaccines Market (Million US$), 2005 – 2011
Figure 6 45: Worldwide – Forecast for Hepatitis Pediatric Vaccines Market (Million US$), 2012 – 2015
Figure 6 46: Worldwide – Number of Doses of Varicella Vaccines (Million Doses), 2005 – 2011
Figure 6 47: Worldwide – Forecast for Number of Doses of Varicella Vaccines (Million Doses), 2012 – 2015
Figure 6 48: Worldwide – Varicella Vaccines Market (Million US$), 2005 – 2011
Figure 6 49: Worldwide – Forecast for Varicella Vaccines Market (Million US$), 2012 – 2015
Figure 6 50: Worldwide – Other Pediatric Vaccines Market (Million US$), 2005 – 2011
Figure 6 51: Worldwide – Forecast for Other Pediatric Vaccines Market (Million US$),2012 – 2015

Figure 7 1: Prices of Childhood Vaccines (US$), 2011
Figure 7 2: Reduction in Rotavirus Vaccine Prices (US$), May 2011 & April 2012
Figure 7 3: Increasing Number of GAVI Suppliers Based in Emerging Markets

List of Tables

Table 4 1: Worldwide (Disease wise) – Pediatric Vaccines Market Share (Percent), 2006 – 2011
Table 4 2: Worldwide (Disease wise) – Forecast for Pediatric Vaccines Market Share (Percent), 2012 – 2015

Table 6 1: Worldwide (By Geographic Region) – Number of Measles Cases (Number), 2001 – 2011
Table 6 2: Worldwide (By Geographic Region) – Number of Mumps Cases (Number), 2001 – 2011
Table 6 3: Worldwide (By Geographic Region) – Number of Rubella Cases (Number), 2001 – 2011
Table 6 4: Worldwide (By Geographic Region) – Number of Haemophilus Influenzae Type B Meningitis Cases (Number), 2001 – 2011
Table 6 5: Worldwide (By Geographic Region) – Number of Polio Cases (Number), 2001 – 2011
Table 6 6: Worldwide (By Geographic Region) – Number of Diphtheria Cases (Number), 2001 – 2011
Table 6 7: Worldwide (By Geographic Region) – Number of nTetanus Cases (Number), 2001 – 2011
Table 6 8: Worldwide (By Geographic Region) – Number of tTetanus Cases (Number), 2001 – 2011
Table 6 9: Worldwide (By Geographic Region) – Number of Pertusis Cases (Number), 2001 – 2011
Table 6 10: Worldwide (By Geographic Region) – Pneumococcal Cases & Death in Children Under 5 Years of Age (Number), 2000
Table 6 11: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance (Number), 2008 – 2009
Table 6 12: Worldwide (By Geographic Region) – WHO Coordinated Rotavirus Surveillance Positive Cases (Number & Percent), 2009

Table 7 1: Worldwide – Total Future Deaths Averted through Vaccination (Million), 2011 – 2020
Table 7 2: Goal-Level Indicators, 2015 & 2020

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos